Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_assertion type Assertion NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_head.
- NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_assertion description "[We have studied, using monoclonal antibodies for immunohistochemistry, the Id1 and Id3 tumor epithelial expression in 17 patients with stage III-N2 non-small cell lung cancer (NSCLC) treated with definitive chemoradiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_provenance.
- NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_assertion evidence source_evidence_literature NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_provenance.
- NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_assertion SIO_000772 23311395 NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_provenance.
- NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_assertion wasDerivedFrom befree-20140225 NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_provenance.
- NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_assertion wasGeneratedBy ECO_0000203 NP259635.RAolZ0Ow9n0qJs22t_aTTurm2P17_wdcwlyFSNkPR6cJM130_provenance.